{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:03:08Z","timestamp":1792436588834,"version":"4.5.0"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007395","name":"Instituto Nacional de Ci\u00eancia e Tecnologia para Excitotoxicidade e Neuroprote\u00e7\u00e3o","doi-asserted-by":"publisher","award":["UID\/EQU\/00102\/2019"],"award-info":[{"award-number":["UID\/EQU\/00102\/2019"]}],"id":[{"id":"10.13039\/501100007395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejmech.2020.112327","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T11:44:15Z","timestamp":1588679055000},"page":"112327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Epoxide containing molecules: A good or a bad drug design approach"],"prefix":"10.1016","volume":"201","author":[{"given":"Ana R.","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla L.","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisi\u00e1rio J.","family":"Tavares-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda M.F.","family":"Roleira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejmech.2020.112327_bib1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.steroids.2009.07.009","article-title":"Synthesis and evaluation of some steroidal oximes as cytotoxic agents: structure\/activity studies (II)","volume":"74","author":"Cui","year":"2009","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2020.112327_bib2","first-page":"208","article-title":"The organic chemistry of drug design and drug action","volume":"85","author":"Silverman","year":"2014","journal-title":"J.\u00a0Chem. Educ."},{"issue":"30","key":"10.1016\/j.ejmech.2020.112327_bib3","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1016\/S0040-4020(01)85362-X","article-title":"Chemical and biological synthesis of chiral epoxides","volume":"50","author":"Besse","year":"1994","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2020.112327_bib4","first-page":"317","article-title":"Epoxides \u2013 is there a human health problem?","volume":"37","author":"Manson","year":"1980","journal-title":"Br. J. Ind. Med."},{"issue":"4","key":"10.1016\/j.ejmech.2020.112327_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/acscentsci.5b00131","article-title":"Modeling epoxidation of drug-like molecules with a deep machine learning network","volume":"1","author":"Hughes","year":"2015","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2020.112327_bib6","first-page":"1","article-title":"Cadmium, nickel, some epoxides, miscellaneous industrial chemicals and general considerations on volatile anaesthetics","volume":"11","author":"IARC Epoxides","year":"1976"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biochi.2012.06.011","article-title":"Role of epoxide hydrolases in lipid metabolism","volume":"95","author":"Morisseau","year":"2013","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0167-7799(97)01161-X","article-title":"Epoxide hydrolases: new tools for the synthesis of fine organic chemicals","volume":"16","author":"Archelas","year":"1998","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ejmech.2020.112327_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0076-6879(05)00032-7","article-title":"Epoxide hydrolases: structure, function, mechanism, and assay","volume":"400","author":"Arand","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2020.112327_bib10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nm0597-562","article-title":"Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase","volume":"3","author":"Moghaddam","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2020.112327_bib11","series-title":"The Practice of Medicinal Chemistry","author":"Wermuth","year":"2008"},{"issue":"6","key":"10.1016\/j.ejmech.2020.112327_bib12","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1021\/cr980013j","article-title":"Naturally occurring cyclohexane epoxides: sources, biological activities and synthesis","volume":"104","author":"Marco-Contelles","year":"2004","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib13","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1021\/cr200073d","article-title":"Enzymatic chemistry of cyclopropane, epoxide, and aziridine biosynthesis","volume":"112","author":"Thibodeaux","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2020.112327_bib14","series-title":"Epoxy Resins: Chemistry and Technology","article-title":"Synthesis and characteristics of epoxides","author":"Tanaka","year":"1988"},{"key":"10.1016\/j.ejmech.2020.112327_bib15","series-title":"Comprehensive Organic Chemistry","article-title":"Addition reactions with formation of carbon-oxygen bonds: (i) general methods of epoxidation in comprehensive organic synthesis","author":"Rao","year":"1991"},{"key":"10.1016\/j.ejmech.2020.112327_bib16","series-title":"Organic Chemistry","author":"McMurry","year":"2010"},{"key":"10.1016\/j.ejmech.2020.112327_bib17","series-title":"Organic Chemistry","author":"Carey","year":"2011"},{"key":"10.1016\/j.ejmech.2020.112327_bib18","series-title":"The Chemistry of Functional Groups","doi-asserted-by":"crossref","DOI":"10.1002\/9780470771075","article-title":"The chemistry of the ether linkage","author":"Patai","year":"1967"},{"issue":"8","key":"10.1016\/j.ejmech.2020.112327_bib19","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1021\/jm300262w","article-title":"New structure-activity relationships of A-and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation","volume":"55","author":"Varela","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2020.112327_bib20","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1021\/jm050129p","article-title":"Structure\u2212Activity relationships of new A,D-Ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation","volume":"48","author":"Cepa","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2020.112327_bib21","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1021\/acs.jmedchem.9b00157","article-title":"C-6\u03b1- vs C-7\u03b1-Substituted steroidal aromatase inhibitors: which is better? Synthesis, biochemical evaluation, docking studies, and structure-activity relationships","volume":"62","author":"Roleira","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2020.112327_bib22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/cr00020a002","article-title":"Substrate-directable chemical reactions","volume":"93","author":"Hoveyda","year":"1993","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.ejmech.2020.112327_bib23","first-page":"1100","article-title":"Selenoxides as catalysts for epoxidation and Baeyer-Villiger oxidation with hydrogen peroxide","author":"Goodman","year":"2006","journal-title":"Synlett"},{"issue":"4","key":"10.1016\/j.ejmech.2020.112327_bib24","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1021\/ja411379e","article-title":"Tungsten-catalyzed asymmetric epoxidation of allylic and homoallylic alcohols with hydrogen peroxide","volume":"136","author":"Wang","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.ejmech.2020.112327_bib25","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1021\/jo5003938","article-title":"2,2,2-Trifluoroacetophenone: an organocatalyst for an environmentally friendly epoxidation of alkenes","volume":"79","author":"Limnios","year":"2014","journal-title":"J.\u00a0Org. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/adsc.200800650","article-title":"A\u00a0broad substrate-scope method for fast, efficient and selective hydrogen peroxide-epoxidation","volume":"351","author":"Garcia-Bosch","year":"2008","journal-title":"Adv. Synth. Catal."},{"issue":"11","key":"10.1016\/j.ejmech.2020.112327_bib27","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1021\/acs.orglett.6b00518","article-title":"Manganese(II)\/Picolinic acid catalyst system for epoxidation of olefins","volume":"18","author":"Moretti","year":"2016","journal-title":"Org. Lett."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3998\/ark.5550190.0007.302","article-title":"Epoxides and aziridines - a mini review","author":"Padwa","year":"2006","journal-title":"Arkivoc"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.micro.51.1.491","article-title":"Synthesis of enantiopure epoxides through biocatalytic approaches","volume":"51","author":"Archelas","year":"1997","journal-title":"Annu. Rev. Microbiol."},{"issue":"43","key":"10.1016\/j.ejmech.2020.112327_bib30","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1016\/j.tet.2003.09.033","article-title":"Conversion of epoxides into halohydrins with elemental halogen catalyzed by thiourea","volume":"59","author":"Sharghi","year":"2003","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsbmb.2012.12.017","article-title":"Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy","volume":"135","author":"Amaral","year":"2013","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"issue":"11","key":"10.1016\/j.ejmech.2020.112327_bib32","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s10495-013-0879-6","article-title":"Steroidal aromatase inhibitors inhibit growth of hormone-dependent breast cancer cells by inducing cell cycle arrest and apoptosis","volume":"18","author":"Amaral","year":"2013","journal-title":"Apoptosis"},{"issue":"12","key":"10.1016\/j.ejmech.2020.112327_bib33","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1016\/j.bmc.2016.04.056","article-title":"Exploring new chemical functionalities to improve aromatase inhibition of steroids","volume":"24","author":"Varela","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112327_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2121-9-41","article-title":"New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death","volume":"9","author":"Cepa","year":"2008","journal-title":"BMC Cell Biol."},{"issue":"14","key":"10.1016\/j.ejmech.2020.112327_bib35","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.steroids.2008.07.001","article-title":"Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors","volume":"73","author":"Cepa","year":"2008","journal-title":"Steroids"},{"issue":"9","key":"10.1016\/j.ejmech.2020.112327_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1515\/BC.2008.134","article-title":"Molecular mechanisms of aromatase inhibition by new A, D-ring modified steroids","volume":"389","author":"Cepa","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112327_bib37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejmech.2014.09.074","article-title":"Exemestane metabolites: synthesis, stereochemical elucidation, biochemical activity and anti-proliferative effects in a hormone-dependent breast cancer cell line","volume":"87","author":"Varela","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112327_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biocel.2015.10.024","article-title":"Exemestane metabolites suppress growth of estrogen receptor-positive breast cancer cells by inducing apoptosis and autophagy: a comparative study with Exemestane","volume":"69","author":"Amaral","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.ejmech.2020.112327_bib39","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1021\/np0200459","article-title":"Novel cytotoxic oxygenated C29 sterols from the Colombian marine sponge Polymastia tenax","volume":"65","author":"Santaf\u00e9","year":"2002","journal-title":"J.\u00a0Nat. Prod."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112327_bib40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.steroids.2008.02.006","article-title":"Synthesis and biological evaluation of some new A,B-ring modified steroidal d-lactones","volume":"73","author":"Djurendi\u0107","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2020.112327_bib41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jsbmb.2017.04.002","article-title":"Anti-tumor efficacy of new 7\u03b1-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells","volume":"171","author":"Amaral","year":"2017","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib42","first-page":"219","article-title":"Advances of coagulation factor XIII","volume":"130","author":"Shi","year":"2017","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.ejmech.2020.112327_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2015.05.019","article-title":"(\u00b1) cis-bisamido epoxides: a novel series of potent FXIII-A inhibitors","volume":"98","author":"Avery","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112327_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.150","article-title":"Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death","volume":"7","author":"Tatsukawa","year":"2016","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.ejmech.2020.112327_bib45","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.7164\/antibiotics.37.1264","article-title":"Chemical modification and antitumor activity of herbimycin A. 8,9-Epoxide, 7,9-cyclic carbamate, and 17 or 19-amino derivatives","volume":"37","author":"Omura","year":"1984","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"issue":"4","key":"10.1016\/j.ejmech.2020.112327_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4155\/fmc-2016-0229","article-title":"The potential of combi-molecules with DNA-damaging function as anticancer agents","volume":"9","author":"Sun","year":"2017","journal-title":"Future Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2020.112327_bib47","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1021\/jm030096i","article-title":"Design, synthesis, and evaluation of psorospermin\/quinobenzoxazine hybrids as structurally novel antitumor agents","volume":"46","author":"Kim","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2020.112327_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1470-2045(02)00715-5","article-title":"Culprit and victim -- DNA topoisomerase II","volume":"3","author":"Kellner","year":"2002","journal-title":"Lancet Oncol."},{"issue":"November 2018","key":"10.1016\/j.ejmech.2020.112327_bib49","first-page":"347","article-title":"The synthesis and anticancer activities of chiral epoxy-substituted chromone analogs","volume":"84","author":"Cho","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2020.112327_bib50","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1007\/s00253-019-09711-4","article-title":"Naturally occurring of \u03b1,\u03b2-diepoxy-containing compounds: origin, structures, and biological activities","volume":"103","author":"Vil","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00044-017-1779-z","article-title":"Effect of citral and citral related compounds on viability of pancreatic and human B-lymphoma cell lines","volume":"26","author":"Di Mola","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112327_bib52","volume":"vol. 2","author":"Rose S","year":"2008"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00280-007-0585-6","article-title":"Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer","volume":"62","author":"Bailey","year":"2008","journal-title":"Canc. Chemother. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejmech.2020.112327_bib54","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.3390\/molecules200713264","article-title":"Evaluation of the cytotoxicity of structurally correlated p-menthane derivatives","volume":"20","author":"Andrade","year":"2015","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/ijms17010032","article-title":"In\u00a0vivo anti-tumor activity and toxicological evaluations of perillaldehyde 8,9-epoxide, a derivative of perillyl alcohol","volume":"17","author":"Andrade","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1449","key":"10.1016\/j.ejmech.2020.112327_bib56","first-page":"1","article-title":"(+)-limonene 1,2-epoxide-loaded slns: evaluation of drug release, antioxidant activity, and cytotoxicity in an HaCaT cell line","volume":"21","author":"Souto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"30","key":"10.1016\/j.ejmech.2020.112327_bib57","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5897\/JMPR2018.6699","article-title":"Evaluation of cytotoxic and antitumor activity of perillaldehyde 1,2-epoxide","volume":"12","author":"Luciana","year":"2018","journal-title":"J.\u00a0Med. Plants Res."},{"issue":"161","key":"10.1016\/j.ejmech.2020.112327_bib58","first-page":"1","article-title":"Perillaldehyde 1,2-epoxide loaded SLN-tailored mAb: production, physicochemical characterization and in\u00a0vitro cytotoxicity profile in MCF-7 cell lines","volume":"12","author":"Souto","year":"2020","journal-title":"Pharmaceutics"},{"issue":"17","key":"10.1016\/j.ejmech.2020.112327_bib59","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1080\/14786419.2018.1448813","article-title":"Anti-Leishmania and cytotoxic activities of perillaldehyde epoxide synthetic positional isomers","volume":"33","author":"Keesen","year":"2019","journal-title":"Nat. Prod. Res."},{"issue":"52","key":"10.1016\/j.ejmech.2020.112327_bib60","first-page":"1","article-title":"Bioinspired-metalloporphyrin magnetic nanocomposite as a reusable catalyst for synthesis of diastereomeric (-)-isopulegol epoxide: anticancer activity against human osteosarcoma cells (MG-63)","volume":"24","author":"Dias","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ejmech.2020.112327_bib61","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1021\/np0500575","article-title":"Cytotoxic activity of some natural and synthetic Guaianolides","volume":"68","author":"Bruno","year":"2005","journal-title":"J.\u00a0Nat. Prod."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1871520617666170918130126","article-title":"Antileukemic properties of sesquiterpene lactones: a systematic review","volume":"18","author":"da Silva Castro","year":"2018","journal-title":"Anticanc. Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/jm00235a013","article-title":"Antitumor agents. 11. Synthesis and cytotoxic activity of epoxides of helenalin related derivatives","volume":"18","author":"Lee","year":"1975","journal-title":"J.\u00a0Med. Chem."},{"issue":"247685","key":"10.1016\/j.ejmech.2020.112327_bib64","article-title":"Sesquiterpene lactones from Artemisia Genus\u00a0: biological activities and methods of analysis","volume":"2015","author":"Ivanescu","year":"2015","journal-title":"J.\u00a0Anal. Methods Chem."},{"key":"10.1016\/j.ejmech.2020.112327_bib65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ardp.201100065","article-title":"Synthesis and biological evaluation of antitumor-active arglabin derivatives","volume":"345","author":"Csuk","year":"2012","journal-title":"Arch. Pharm. Chem. Life Sci."},{"issue":"August","key":"10.1016\/j.ejmech.2020.112327_bib66","first-page":"1585","article-title":"Arglabin as a potential drug in the treatment of Freund \u2019 s complete adjuvant-induced arthritis in rats","volume":"17","author":"Jia","year":"2018","journal-title":"Trop. J. Pharmaceut. Res."},{"issue":"12","key":"10.1016\/j.ejmech.2020.112327_bib67","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.114.013730","article-title":"Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet","volume":"131","author":"Abderrazak","year":"2015","journal-title":"Circulation"},{"issue":"January","key":"10.1016\/j.ejmech.2020.112327_bib68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.indcrop.2018.02.046","article-title":"Valorization of essential oils from two populations (wild and commercial) of Geranium macrorrhizum L","volume":"116","author":"Navarro-Rocha","year":"2018","journal-title":"Ind. Crop. Prod."},{"issue":"2898","key":"10.1016\/j.ejmech.2020.112327_bib69","first-page":"1","article-title":"Germacrone derivatives as new insecticidal","volume":"24","author":"AC","year":"2019","journal-title":"Molecules"},{"issue":"24","key":"10.1016\/j.ejmech.2020.112327_bib70","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1111\/j.1742-4658.2006.05560.x","article-title":"Ixocarpalactone A isolated from the Mexican tomatillo shows potent antiproliferative and apoptotic activity in colon cancer cells","volume":"273","author":"Choi","year":"2006","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.ejmech.2020.112327_bib71","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1349-7006.2011.01900.x","article-title":"Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways","volume":"102","author":"Qi","year":"2011","journal-title":"Canc. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib72","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.118.254516","article-title":"Cinobufacini ameliorates dextran sulfate sodium\u2013induced colitis in mice through inhibiting M1 macrophage polarization","volume":"368","author":"Wang","year":"2019","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.ejmech.2020.112327_bib73","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/bmc.322","article-title":"Simultaneous determination of four bufadienolides in human liver by high-performance liquid chromatography","volume":"18","author":"Wang","year":"2004","journal-title":"Biomed. Chromatogr."},{"issue":"40","key":"10.1016\/j.ejmech.2020.112327_bib74","doi-asserted-by":"crossref","first-page":"25175","DOI":"10.1039\/C7RA01085K","article-title":"Cinobufagin, a bufadienolide, activates ROS-mediated pathways to trigger human lung cancer cell apoptosis in\u00a0vivo","volume":"7","author":"Peng","year":"2017","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/pros.10172","article-title":"Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells","volume":"54","author":"Yeh","year":"2003","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib76","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1159\/000488842","article-title":"Cinobufagin induces apoptosis in osteosarcoma cells via the mitochondria-mediated apoptotic pathway","volume":"46","author":"Dai","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"35","key":"10.1016\/j.ejmech.2020.112327_bib77","doi-asserted-by":"crossref","first-page":"988","DOI":"10.18632\/oncotarget.13519","article-title":"Preclinical study of cinobufagin as a promising anti-colorectal cancer agent","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1580-x","article-title":"Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis","volume":"16","author":"Han","year":"2018","journal-title":"J.\u00a0Transl. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib79","first-page":"3297","article-title":"Anticancer effect of resibufogenin on gastric carcinoma cells through the phosphoinositide 3-kinase\/protein kinase B\/glycogen synthase kinase 3\u03b2 signaling pathway","volume":"16","author":"Lu","year":"2018","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.ejmech.2020.112327_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0044039","article-title":"A\u00a0novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular par-4","volume":"7","author":"Rah","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib81","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/15548627.2015.1017182","article-title":"PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells","volume":"11","author":"Rah","year":"2015","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib82","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3329\/bjp.v11i1.24575","article-title":"Alloimperatorin and its epoxide derivative exhibit in\u00a0vitro antitumor activity in HL-60 acute myeloid leukemia cancer cells via inducing apoptosis, cell cycle disruption and inhibition of cell migration","volume":"11","author":"Li","year":"2016","journal-title":"Bangladesh J. Pharmacol."},{"issue":"13","key":"10.1016\/j.ejmech.2020.112327_bib83","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.phytochem.2008.06.019","article-title":"Antitumoral and antileishmanial dioncoquinones and ancistroquinones from cell cultures of Triphyophyllum peltatum (Dioncophyllaceae) and Ancistrocladus abbreviatus (Ancistrocladaceae)","volume":"69","author":"Bringmann","year":"2008","journal-title":"Phytochemistry"},{"issue":"38","key":"10.1016\/j.ejmech.2020.112327_bib84","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1016\/j.tet.2018.04.056","article-title":"Epoxides related to dioncoquinone B: synthesis, activity against multiple myeloma cells, and search for the target protein","volume":"74","author":"Cheng","year":"2018","journal-title":"Tetrahedron"},{"issue":"11","key":"10.1016\/j.ejmech.2020.112327_bib85","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/bies.201600070","article-title":"Histone deacetylase inhibitors for cancer therapy: an evolutionarily ancient resistance response may explain their limited success","volume":"38","author":"Halsall","year":"2016","journal-title":"Bioessays"},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib86","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/jpet.102.042903","article-title":"Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin","volume":"304","author":"De Schepper","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.ejmech.2020.112327_bib87","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3892\/or.2016.4636","article-title":"Histone deacetylase inhibitor screening identifies HC toxin as the most effective in intrahepatic cholangiocarcinoma cells","volume":"35","author":"Zhou","year":"2016","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112327_bib88","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/BF02980164","article-title":"Antiproliferative effect of trichostatin a and hc-toxin in T47D Human breast cancer cells","volume":"27","author":"Joung","year":"2004","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib89","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2008.01.002","article-title":"Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in\u00a0vitro","volume":"264","author":"Deubzer","year":"2008","journal-title":"Canc. Lett."},{"issue":"7","key":"10.1016\/j.ejmech.2020.112327_bib90","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1021\/np500387h","article-title":"A\u00a0potent HDAC inhibitor, 1-alaninechlamydocin, from a Tolypocladium sp. induces G2\/M cell cycle arrest and apoptosis in MIA PaCa-2 cells","volume":"77","author":"Du","year":"2014","journal-title":"J.\u00a0Nat. Prod."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112327_bib91","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/0192623312444471","article-title":"A\u00a0comprehensive review of the carcinogenic and anticarcinogenic potential of capsaicin","volume":"40","author":"Bley","year":"2012","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib92","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1179\/1351000214Y.0000000113","article-title":"Oxidant-based anticancer activity of a novel synthetic analogue of capsaicin, capsaicin epoxide","volume":"20","author":"Lewinska","year":"2015","journal-title":"Redox Rep."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib93","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3565(24)39088-3","article-title":"Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth","volume":"294","author":"Udagawa","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2020.112327_bib94","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/np3007364","article-title":"Ligerin, an antiproliferative chlorinated sesquiterpenoid from a marine-derived Penicillium strain","volume":"76","author":"Strain","year":"2013","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2020.112327_bib95","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejmech.2014.04.012","article-title":"Synthesis and antiproliferative activity of ligerin and new fumagillin analogs against osteosarcoma","volume":"79","author":"Guitton","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib96","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/AAC.00609-07","article-title":"Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphology","volume":"52","author":"Crespo","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"17","key":"10.1016\/j.ejmech.2020.112327_bib97","doi-asserted-by":"crossref","first-page":"9389","DOI":"10.1073\/pnas.94.17.9389","article-title":"Variations in frequencies of drug resistance in Plasmodium falciparum","volume":"94","author":"Rathod","year":"1997","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"S1","key":"10.1016\/j.ejmech.2020.112327_bib98","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ejmech.2020.112327_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111652","article-title":"Highly potent non-steroidal FXR agonists protostane-type triterpenoids: structure-activity relationship and mechanism","volume":"182","author":"Luan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib100","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.taap.2015.01.020","article-title":"Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis","volume":"283","author":"Meng","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejmech.2020.112327_bib101","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1055\/s-2006-947178","article-title":"A\u00a0new triterpene and anti-hepatitis B virus active compounds from Alisma orientalis","volume":"72","author":"Jiang","year":"2006","journal-title":"Planta Med."},{"issue":"4","key":"10.1016\/j.ejmech.2020.112327_bib102","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.bbrc.2018.10.022","article-title":"Alisol B-23-acetate, a tetracyclic triterpenoid isolated from Alisma orientale, induces apoptosis in human lung cancer cells via the mitochondrial pathway","volume":"505","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"23","key":"10.1016\/j.ejmech.2020.112327_bib103","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.3748\/wjg.15.2870","article-title":"Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases\/Akt signaling pathways","volume":"15","author":"Xu","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.ejmech.2020.112327_bib104","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s12272-012-1108-5","article-title":"A\u00a0new triterpenoid from Alisma orientale and their antibacterial effect","volume":"35","author":"Jin","year":"2012","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2020.112327_bib105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.fitote.2013.05.007","article-title":"Chemical constituents of Callicarpa nudiflora and their anti-platelet aggregation activity","volume":"88","author":"Zhou","year":"2013","journal-title":"Fitoterapia"},{"issue":"July","key":"10.1016\/j.ejmech.2020.112327_bib106","article-title":"Five 11\u03b1, 12\u03b1-epoxy pentacyclic triterpenoid saponins with antithrombus activities from Glechoma longituba","volume":"138","author":"Ouyang","year":"2019","journal-title":"Fitoterapia"},{"issue":"8","key":"10.1016\/j.ejmech.2020.112327_bib107","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bmcl.2019.02.015","article-title":"Structure-activity relationships of trichothecenes against COLO201 cells and Cochliobolus miyabeanus: the role of 12-epoxide and macrocyclic moieties","volume":"29","author":"Matsumoto","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib108","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.intimp.2011.01.012","article-title":"Triptolide and its expanding multiple pharmacological functions","volume":"11","author":"Liu","year":"2011","journal-title":"Int. Immunopharm."},{"issue":"23","key":"10.1016\/j.ejmech.2020.112327_bib109","doi-asserted-by":"crossref","first-page":"9334","DOI":"10.1021\/acs.jmedchem.5b01329","article-title":"Phosphonooxymethyl prodrug of triptolide: synthesis, physicochemical characterization, and efficacy in human colon adenocarcinoma and ovarian cancer xenografts","volume":"58","author":"Patil","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"issue":"156","key":"10.1016\/j.ejmech.2020.112327_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004334","article-title":"A\u00a0preclinical evaluation of minnelide as a therapeutic agent against pancreatic cancer","volume":"4","author":"Chugh","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2020.112327_bib111","series-title":"A\u00a0Phase II, International Open Label Trial of Minnelide in Patients with Refractory Pancreatic Cancer","year":"2017"},{"issue":"8","key":"10.1016\/j.ejmech.2020.112327_bib112","first-page":"2666","article-title":"Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells","volume":"8","author":"Kiviharju","year":"2002","journal-title":"Clin. Canc. Res."},{"issue":"8","key":"10.1016\/j.ejmech.2020.112327_bib113","first-page":"744","article-title":"Cryptophycins: potent antitumor depsipeptides from the blue-green alga Nostoc sp CA123:164737","volume":"36","author":"Trimurtulu","year":"1994","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"2\u20133","key":"10.1016\/j.ejmech.2020.112327_bib114","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01573860","article-title":"Pharmaceuticals from cultured algae","volume":"5","author":"Schwartz","year":"1990","journal-title":"J.\u00a0Ind. Microbiol."},{"issue":"14","key":"10.1016\/j.ejmech.2020.112327_bib115","first-page":"3779","article-title":"Cryptophycin: a new antimicrotubule agent active against drug-resistant cells","volume":"54","author":"Smith","year":"1994","journal-title":"Canc. Res."},{"issue":"12","key":"10.1016\/j.ejmech.2020.112327_bib116","first-page":"3922","article-title":"The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells","volume":"8","author":"Drew","year":"2002","journal-title":"Clin. Canc. Res."},{"issue":"11","key":"10.1016\/j.ejmech.2020.112327_bib117","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1074\/jbc.271.11.6192","article-title":"Mechanism of action of cryptophycin","volume":"271","author":"Smith","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2020.112327_bib118","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1016\/j.bmc.2014.02.035","article-title":"Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function","volume":"22","author":"Field","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2020.112327_bib119","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1021\/pr800388p","article-title":"Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibition","volume":"7","author":"Warder","year":"2008","journal-title":"J.\u00a0Proteome Res."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1124\/jpet.117.246272","article-title":"Preclinical efficacy and safety of the novel antidiabetic, antiobesity MetAP2 inhibitor ZGN-1061","volume":"365","author":"Burkey","year":"2018","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib121","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ijc.20687","article-title":"Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model","volume":"114","author":"Chun","year":"2005","journal-title":"Int. J. Canc."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib122","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1248\/bpb.28.217","article-title":"General pharmacology of CKD-732, a new anticancer agent: effects on central nervous, cardiovascular, and respiratory system","volume":"28","author":"Kim","year":"2005","journal-title":"Biol. Pharm. Bull."},{"issue":"16","key":"10.1016\/j.ejmech.2020.112327_bib123","doi-asserted-by":"crossref","first-page":"10730","DOI":"10.1073\/pnas.162349799","article-title":"Adipose tissue mass can be regulated through the vasculature","volume":"99","author":"Rupnick","year":"2002","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"3\u20134","key":"10.1016\/j.ejmech.2020.112327_bib124","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1677\/jme.1.02165","article-title":"Assessment of the anti-obesity effects of the TNP-470 analog CKD-732","volume":"38","author":"Kim","year":"2007","journal-title":"J.\u00a0Mol. Endocrinol."},{"issue":"9","key":"10.1016\/j.ejmech.2020.112327_bib125","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/oby.20356","article-title":"Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women","volume":"21","author":"Hughes","year":"2013","journal-title":"Obesity"},{"issue":"6","key":"10.1016\/j.ejmech.2020.112327_bib126","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/dom.12457","article-title":"Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial","volume":"17","author":"Kim","year":"2015","journal-title":"Diabetes Obes. Metabol."},{"issue":"9","key":"10.1016\/j.ejmech.2020.112327_bib127","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1007\/s00125-018-4677-0","article-title":"Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial","volume":"61","author":"Proietto","year":"2018","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.ejmech.2020.112327_bib128","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/dom.13305","article-title":"Single and multiple dose evaluation of a novel MetAP2 inhibitor: results of a randomized, double-blind, placebo-controlled clinical trial","volume":"20","author":"Malloy","year":"2018","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejmech.2020.112327_bib129","series-title":"Results of an Interim Analysis of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of ZGN-1061 in Patients with Type 2 Diabetes and Obesity: Update with Full Results","author":"Kim","year":"2018"},{"issue":"47","key":"10.1016\/j.ejmech.2020.112327_bib130","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1002\/anie.200602785","article-title":"Total synthesis and antitumor activity of ZK-EPO: the first fully synthetic epothilone in clinical development","volume":"45","author":"Klar","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib131","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1215\/15228517-2008-072","article-title":"Sagopilone crosses the blood-brain barrier in\u00a0vivo to inhibit brain tumor growth and metastases","volume":"11","author":"Hoffmann","year":"2008","journal-title":"Neuro Oncol."},{"issue":"8","key":"10.1016\/j.ejmech.2020.112327_bib132","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/sj.bjc.6605327","article-title":"Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase i trial","volume":"101","author":"Arnold","year":"2009","journal-title":"Br. J. Canc."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112327_bib133","first-page":"376","article-title":"A\u00a0phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases","volume":"11","author":"Freedman","year":"2011","journal-title":"Clin. Breast Canc."},{"issue":"9","key":"10.1016\/j.ejmech.2020.112327_bib134","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/annonc\/mdq729","article-title":"Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European organisation for research and treatment of cancer (EORTC) brain tumor group","volume":"22","author":"Stupp","year":"2011","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00280-004-0928-5","article-title":"Preclinical pharmacokinetics and oral bioavailability of BMS-310705, a novel epothilone B analog","volume":"56","author":"Kamath","year":"2005","journal-title":"Canc. Chemother. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejmech.2020.112327_bib136","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/annonc\/mdm198","article-title":"Phase I clinical study of the novel epothilone B analogue BMS-310705 given on a weekly schedule","volume":"18","author":"Sessa","year":"2007","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112327_bib137","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00280-008-0695-9","article-title":"Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in\u00a0vitro and in\u00a0vivo","volume":"62","author":"O\u2019Reilly","year":"2008","journal-title":"Canc. Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2020.112327_bib138","first-page":"789","article-title":"Novel microtubule-targeting agents - the epothilones","volume":"2","author":"Cheng","year":"2008","journal-title":"Biol. Targets & Ther."},{"issue":"36","key":"10.1016\/j.ejmech.2020.112327_bib139","doi-asserted-by":"crossref","first-page":"9120","DOI":"10.1200\/JCO.2005.03.0981","article-title":"Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors","volume":"23","author":"Rubin","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"23","key":"10.1016\/j.ejmech.2020.112327_bib140","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1002\/cncr.29636","article-title":"Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer","volume":"121","author":"Nayak","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejmech.2020.112327_bib141","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/neuonc\/not305","article-title":"Phase II trial of patupilone in patients with brain metastases from breast cancer","volume":"16","author":"Peereboom","year":"2014","journal-title":"Neuro Oncol."},{"issue":"31","key":"10.1016\/j.ejmech.2020.112327_bib142","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1200\/JCO.2011.38.8082","article-title":"Randomized, open-label, phase III study comparing patupilone (EPO906) with pegylated liposomal doxorubicin in platinum-refractory or -resistant patients with recurrent epithelial ovarian, primary fallopian tube, or primary peritoneal cancer","volume":"30","author":"Colombo","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ejmech.2020.112327_bib143","first-page":"334","article-title":"Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review","volume":"5","author":"Mishra","year":"2000","journal-title":"Alternative Med. Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib144","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10456-004-1026-3","article-title":"Withaferin A is a potent inhibitor of angiogenesis","volume":"7","author":"Mohan","year":"2004","journal-title":"Angiogenesis"},{"issue":"6","key":"10.1016\/j.ejmech.2020.112327_bib145","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2007.04.010","article-title":"The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin","volume":"14","author":"Bargagna-mohan","year":"2007","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib146","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lfs.2003.07.007","article-title":"Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves","volume":"74","author":"Jayaprakasam","year":"2003","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib147","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.steroids.2007.10.006","article-title":"Selective reactivity of 2-mercaptoethanol with 5\u03b2,6\u03b2-epoxide in steroids from Withania somnifera","volume":"73","author":"Misra","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2020.112327_bib148","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.steroids.2013.10.008","article-title":"Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera","volume":"79","author":"Joshi","year":"2014","journal-title":"Steroids"},{"issue":"19","key":"10.1016\/j.ejmech.2020.112327_bib149","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1002\/1521-3765(20001002)6:19<3517::AID-CHEM3517>3.0.CO;2-#","article-title":"Highly \u03b2-selective epoxidation of \u03945-Unsaturated steroids catalyzed by ketones","volume":"6","author":"Yang","year":"2000","journal-title":"Chem. Eur J."},{"issue":"5","key":"10.1016\/j.ejmech.2020.112327_bib150","article-title":"Adjucntive use of a standardized extract of Withania somnifera (Ashwagandha) to treat symptom exacerbation in schizophrenia: a randomized, double-blind, placedo-controlled study","volume":"79","author":"Chengappa","year":"2018","journal-title":"J.\u00a0Clin. Phychiatr."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib151","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10753-011-9346-0","article-title":"Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities","volume":"35","author":"Mathema","year":"2012","journal-title":"Inflammation"},{"issue":"23","key":"10.1016\/j.ejmech.2020.112327_bib152","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2174\/0929867323666160510123255","article-title":"Development of anticancer agents from plant-derived sesquiterpene lactones","volume":"23","author":"Ren","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib153","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:DRUG.0000026256.38560.be","article-title":"Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer","volume":"22","author":"Fife","year":"2004","journal-title":"Invest. N. Drugs"},{"issue":"17\u201318","key":"10.1016\/j.ejmech.2020.112327_bib154","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.drudis.2013.05.005","article-title":"Parthenolide: from plant shoots to cancer roots","volume":"18","author":"Ghantous","year":"2013","journal-title":"Drug Discov. Today"},{"issue":"13","key":"10.1016\/j.ejmech.2020.112327_bib155","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1182\/blood-2007-05-090621","article-title":"An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells","volume":"110","author":"Vaughan","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ejmech.2020.112327_bib156","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/pros.21141","article-title":"A\u00a0water-soluble parthenolide analogue suppresses in\u00a0vivo prostate cancer growth by targeting NF\u03baB and generating reactive oxygen species","volume":"70","author":"Shanmugam","year":"2010","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib157","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/15680096113136660108","article-title":"Dimethylaminoparthenolide, A water soluble parthenolide, suppresses lung tumorigenesis through down-regulating the STAT3 signaling pathway","volume":"14","author":"Qian","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib158","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1871520617666170918130126","article-title":"Antileukemic properties of sesquiterpene lactones: a systematic review","volume":"18","author":"da Silva Castro","year":"2018","journal-title":"Anticanc. Agents Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2020.112327_bib159","first-page":"6099","article-title":"The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2","volume":"94","author":"Wen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2020.112327_bib160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-0-387-71518-6_35","article-title":"Satchi-fainaro R. TNP-470\u00a0: the resurrection of the first synthetic","volume":"V","author":"Mann-steinberg","year":"2008","journal-title":"Angiogenesis"},{"issue":"7","key":"10.1016\/j.ejmech.2020.112327_bib161","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2174\/092986712799320709","article-title":"The development of MetAP-2 inhibitors in cancer treatment","volume":"19","author":"Yin","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2020.112327_bib162","first-page":"650","article-title":"A\u00a0phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer","volume":"28","author":"Ahn","year":"2009","journal-title":"Invest. N. Drugs"},{"issue":"4","key":"10.1016\/j.ejmech.2020.112327_bib163","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1124\/dmd.112.048355","article-title":"Metabolites of PPI-2458, a selective, irreversible inhibitor of methionine aminopeptidase-2: structure determination and in\u00a0vivo activity","volume":"41","author":"DeLorey","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib164","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bbrc.2014.08.147","article-title":"Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent","volume":"452","author":"Kai","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2020.112327_bib165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4236\/ojog.2016.66043","article-title":"Cinobufotalin as a novel agent to inhibit in\u00a0vitro epithelial ovarian cancer cell proliferation, migration and invasion","author":"McDowell","year":"2016","journal-title":"Open J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112327_bib166","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cbi.2012.07.005","article-title":"Apoptotic cell death by the novel natural compound, cinobufotalin","volume":"199","author":"Emam","year":"2012","journal-title":"Chem. Biol. Interact."},{"issue":"8","key":"10.1016\/j.ejmech.2020.112327_bib167","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1007\/s13277-015-3245-1","article-title":"Ceramide production mediates cinobufotalin-induced growth inhibition and apoptosis in cultured hepatocellular carcinoma cells","volume":"36","author":"Cheng","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ejmech.2020.112327_bib168","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.2147\/OTT.S196684","article-title":"<p>Cinobufotalin as an effective adjuvant therapy for advanced gastric cancer: a meta-analysis of randomized controlled trials<\/p>","volume":"12","author":"Sun","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejmech.2020.112327_bib169","first-page":"237","article-title":"Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma","volume":"5","author":"Fostier","year":"2012","journal-title":"OncoTargets Ther."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112327_bib170","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2141.2012.09232.x","article-title":"An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and\/or refractory multiple myeloma who have been previously treated with bortezomib","volume":"158","author":"Vij","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"20","key":"10.1016\/j.ejmech.2020.112327_bib171","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1182\/blood-2015-05-643320","article-title":"Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma","volume":"126","author":"Shah","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ejmech.2020.112327_bib172","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1021\/jm801329v","article-title":"Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047)","volume":"52","author":"Zhou","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"issue":"34","key":"10.1016\/j.ejmech.2020.112327_bib173","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/eurheartj\/ehu164","article-title":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study","volume":"35","author":"Montalescot","year":"2014","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib174","first-page":"217","article-title":"Eplerenone (Inspra), a new aldosterone antagonist for the treatment of systemic hypertension and heart failure","volume":"17","author":"Craft","year":"2004","journal-title":"Bumc. Proc."},{"issue":"11","key":"10.1016\/j.ejmech.2020.112327_bib175","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/j.ijid.2011.07.007","article-title":"The revival of fosfomycin","volume":"15","author":"Michalopoulos","year":"2011","journal-title":"Int. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112327_bib176","first-page":"481","article-title":"Pharmacokinetics and oral bioavailability of scopolamine in normal subjects","volume":"6","author":"Putcha","year":"1989","journal-title":"Pharm. Res. Off. J. Am. Assoc. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ejmech.2020.112327_bib177","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.biopsych.2012.09.031","article-title":"Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review","volume":"73","author":"Drevets","year":"2013","journal-title":"Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.ejmech.2020.112327_bib178","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biopsych.2009.11.021","article-title":"Replication of scopolamine\u2019s antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial","volume":"67","author":"Drevets","year":"2010","journal-title":"Biol. Psychiatr."},{"issue":"33","key":"10.1016\/j.ejmech.2020.112327_bib179","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1200\/JCO.2007.12.6557","article-title":"Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment","volume":"25","author":"Thomas","year":"2007","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00280-008-0724-8","article-title":"Preclinical discovery of ixabepilone, a highly active antineoplastic agent","volume":"63","author":"Lee","year":"2008","journal-title":"Canc. Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib181","first-page":"99","article-title":"Phase II trial of weekly ixabepilone in men with metastatic castrate-resistant prostate cancer (E3803): a trial of the Eastern cooperative oncology group","volume":"10","author":"Liu","year":"2012","journal-title":"Clin. Genitourin. Canc."},{"issue":"9","key":"10.1016\/j.ejmech.2020.112327_bib182","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1200\/JCO.2006.08.7304","article-title":"Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas","volume":"25","author":"Aghajanian","year":"2007","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ejmech.2020.112327_bib183","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1021\/acs.joc.0c00123","article-title":"Design, synthesis, and biological investigation of epothilone B analogues featuring lactone, lactam, and carbocyclic macrocycles, epoxide, aziridine, and 1,1-difluorocyclopropane and other fluorine residues","volume":"85","author":"Nicolaou","year":"2020","journal-title":"J.\u00a0Org. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib184","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-291X(76)90958-X","article-title":"Binding of maytansine to rat brain tubulin","volume":"72","author":"Mandelbaum-Shavit","year":"1976","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112327_bib185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2011.03.017","article-title":"Antibody-DM1 conjugates as cancer therapeutics","volume":"307","author":"Lopus","year":"2011","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2020.112327_bib186","first-page":"127","article-title":"Immunoconjugates containing novel Maytansinoids\u00a0: promising anticancer drugs","volume":"52","author":"Gross","year":"1992","journal-title":"Canc. Res."},{"issue":"16S","key":"10.1016\/j.ejmech.2020.112327_bib187","article-title":"Phase II trial of BB-10901 (huN901-DM1) given weekly for four consecutive weeks every 6 weeks in patients with relapsed SCLC and CD56-positive small cell carcinoma","volume":"23","author":"Fossella","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112327_bib188","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1158\/1078-0432.CCR-13-0541","article-title":"Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancer","volume":"20","author":"Krop","year":"2014","journal-title":"Clin. Canc. Res."},{"issue":"19","key":"10.1016\/j.ejmech.2020.112327_bib189","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","article-title":"Trastuzumab emtansine for HER2-positive advanced breast cancer","volume":"367","author":"Verma","year":"2012","journal-title":"N.\u00a0Engl. J. MED."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420302968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420302968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:10:25Z","timestamp":1759327825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420302968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":189,"alternative-id":["S0223523420302968"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112327","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epoxide containing molecules: A good or a bad drug design approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112327"}}